A combined healthy strategy for successful weight loss, weight maintenance and improvement of hepatic lipid metabolism

被引:9
作者
Martinez, Rosario [1 ]
Lopez-Trinidad, Luisa M. [1 ]
Kapravelou, Garyfallia [1 ]
Arrebola, Francisco [2 ]
Galisteo, Milagros [3 ]
Aranda, Pilar [1 ]
Porres, Jesus M. [1 ]
Lopez-Jurado, Maria [1 ]
机构
[1] Univ Granada, Dept Physiol, Inst Nutr & Food Technol INyTA, Ctr Biomed Res CIBM,Inst Res Sport & Hlth IMUDS, Granada 18071, Spain
[2] Univ Granada, Dept Histol, Ctr Biomed Res CIBM, Inst Neurosci, Granada 18071, Spain
[3] Univ Granada, Ctr Biomed Res CIBM, Sch Pharm, Dept Pharmacol, Campus Univ Cartuja S-N, Granada 18071, Spain
关键词
High-fat diet; Obesity; NAFLD; Caloric restriction; Physical exercise; CB1 receptor blockade; AGONIST AM 251; INVERSE AGONIST; BODY-WEIGHT; FOOD-INTAKE; DIET; PROTEIN; NAFLD; ASSAY; RATS; ANTIOXIDANT;
D O I
10.1016/j.jnutbio.2020.108456
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity is critically related with the development of metabolic and pathophysiological alterations among which non-alcoholic fatty liver disease (NAFLD) is of especial relevance. Although there are numerous strategies to successfully treat obesity, the prevention of weight regain still remains challenging for individuals who have undergone weight loss programs. In such context, diet and physical activity are considered essential for the regulation of body weight and lipid metabolism. In this study, rats were fed a high-fat diet (HFD) to induce obesity and alterations in hepatic lipid metabolism. Obese rats were then treated with single or combined strategies of caloric restriction, physical exercise, and/or pharmacological treatment with an appetite suppressant, to lose weight, reverse the obesity-related alterations in hepatic morphology and lipid metabolism and maintain the beneficial effects of the interventions used. HFD induced excess body weight, hepatic steatosis, altered fatty acid profile, dysregulated gene expression of lipogenic and lipolytic enzymes, as well as plasma markers of liver damage, and modifications in liver antioxidant enzyme activity. Such alterations were ameliorated by caloric restriction in combination with a mixed training protocol and/or food-intake inhibitor administration during a weight loss intervention period of 3 weeks, and the beneficial effects remained after 6 weeks of weight maintenance, with some interesting interactions observed. In conclusion, weight loss strategies assayed were efficient at correcting the obesogenic action of a HFD and related alterations in hepatic functionality through different molecular mechanisms. The beneficial effects were also evident along the post-intervention maintenance period to avoid body weight regain. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数:13
相关论文
共 51 条
  • [21] Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management
    Huang, Tony
    Behary, Jason
    Zekry, Amany
    [J]. INTERNAL MEDICINE JOURNAL, 2020, 50 (09) : 1038 - 1047
  • [22] A High-Fat, High-Fructose Diet Induces Antioxidant Imbalance and Increases the Risk and Progression of Nonalcoholic Fatty Liver Disease in Mice
    Jarukamjorn, Kanokwan
    Jearapong, Nattharat
    Pimson, Charinya
    Chatuphonprasert, Andwaranya
    [J]. SCIENTIFICA, 2016, 2016
  • [23] The Combined Intervention with Germinated Vigna radiata and Aerobic Interval Training Protocol Is an Effective Strategy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Alterations Related to the Metabolic Syndrome in Zucker Rats
    Kapravelou, Garyfallia
    Martinez, Rosario
    Nebot, Elena
    Lopez-Jurado, Maria
    Aranda, Pilar
    Arrebola, Francisco
    Cantarero, Samuel
    Galisteo, Milagros
    Porres, Jesus M.
    [J]. NUTRIENTS, 2017, 9 (07)
  • [24] Improvement of the antioxidant and hypolipidaemic effects of cowpea flours (Vigna unguiculata) by fermentation: results of in vitro and in vivo experiments
    Kapravelou, Garyfallia
    Martinez, Rosario
    Andrade, Ana M.
    Lopez Chaves, Carlos
    Lopez-Jurado, Maria
    Aranda, Pilar
    Arrebola, Francisco
    Canizares, Francisco J.
    Galisteo, Milagros
    Porres, Jesus M.
    [J]. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2015, 95 (06) : 1207 - 1216
  • [25] Design and validation of a histological scoring system for nonalcoholic fatty liver disease
    Kleiner, DE
    Brunt, EM
    Van Natta, M
    Behling, C
    Contos, MJ
    Cummings, OW
    Ferrell, LD
    Liu, YC
    Torbenson, MS
    Unalp-Arida, A
    Yeh, M
    McCullough, AJ
    Sanyal, AJ
    [J]. HEPATOLOGY, 2005, 41 (06) : 1313 - 1321
  • [26] GLUTATHIONE PEROXIDASE-ACTIVITY IN RAT LENS AND OTHER TISSUES IN RELATION TO DIETARY SELENIUM INTAKE
    LAWRENCE, RA
    SUNDE, RA
    SCHWARTZ, GL
    HOEKSTRA, WG
    [J]. EXPERIMENTAL EYE RESEARCH, 1974, 18 (06) : 563 - 569
  • [27] LEPAGE G, 1986, J LIPID RES, V27, P114
  • [28] Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases
    Lopez-Vicario, Cristina
    Rius, Bibiana
    Alcaraz-Quiles, Jose
    Garcia-Alonso, Veronica
    Lopategi, Aritz
    Titos, Esther
    Claria, Joan
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 785 : 133 - 143
  • [29] Martinez R, 2018, FOOD FUNCT, V9, P830, DOI [10.1039/c7fo01790a, 10.1039/C7FO01790A]
  • [30] Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats
    Merroun, Ikram
    Sanchez-Gonzalez, Cristina
    Martinez, Rosario
    Lopez-Chaves, Carlos
    Porres, Jesus M.
    Aranda, Pilar
    Llopis, Juan
    Galisteo, Milagros
    Zarzuelo, Antonio
    Errami, Mohammed
    Lopez-Jurado, Maria
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (11): : 1641 - 1650